Interstitial granulomatous drug reaction to anakinra - 24/04/13
, Jeannie Hennessy, MD b, Loren E. Clarke, MD a, b, David R. Adams, MD a, Michael D. Ioffreda, MD a, Emmy M. Graber, MD c, Klaus F. Helm, MD a
Reprint requests: Christie G. Regula, BA, MSIII, 78 University Manor East, Hershey, PA 17033.Abstract |
Interstitial granulomatous drug reactions are an uncommon entity presenting as asymptomatic, annular, erythematous to violaceous plaques. The incidence of such reactions has been increasing with the use of biologic agents. We report, to the best of our knowledge, the first such reaction to the interleukin (IL)-1 inhibitor anakinra. Our patient presented with pink dermal plaques and nodules in the periaxillary region which resolved with discontinuation of anakinra and recurred upon restarting anakinra. Biopsy revealed a diffuse dermal infiltrate of lymphocytes and histiocytes with interspersed neutrophils and eosinophils. Fragmentation and degeneration of collagen and elastic fibers was also present. Withdrawal of anakinra led to complete resolution of the lesions. Interstitial granulomatous drug reactions are increasing in frequency and we add anakinra to the list of causative agents.
Le texte complet de cet article est disponible en PDF.Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 59 - N° 2S
P. S25-S27 - août 2008 Retour au numéro
Article précédent
- Ectomesenchymal chondromyxoid tumor of the anterior aspect of the tongue
- Dilek Seckin, Cuyan Demirkesen, Oya Gurbuz
- Aberrant aquaporin 5 expression in the sweat gland in aquagenic wrinkling of the palms
- Kenji Kabashima, Takatoshi Shimauchi, Miwa Kobayashi, Shoko Fukamachi, Chika Kawakami, Makiko Ogata, Rieko Kabashima, Tomoko Mori, Tomoko Ota, Satoshi Fukushima, Mariko Hara-Chikuma, Yoshiki Tokura
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?